Pharmaceutical Contract Development and Manufacturing Market Research Report
Growth opportunities in the pharmaceutical contract
development and manufacturing market look promising over the next six years.
This is mainly due to the continuous expansion in the product and the
assistance in curtailing expenditures and the increasing demand for
manufacturing competence.
Request
for a FREE Sample Report on Pharmaceutical Contract Development
and Manufacturing Market
Pharmaceutical Contract Development and
Manufacturing Market Dynamics (including market size, share, trends, forecast,
growth, forecast, and industry analysis)
Key
Drivers
The augmenting demand for manufacturing competence is
attaining prominence throughout the world, which the FDA and the US center for
drug evaluation and research are constantly supporting, propelling the pharmaceutical
contract development and manufacturing market share. Also, enormous
countries led by economic adversity are looking for ways to reduce drug
expenditures. Pharma and biotech companies are assigned with the onerous duty
to minimize drug cost, which has led them to evaluate prospects for
manufacturing outsourcing. Asian CMOs are generating ventures into the
transformation and extension of the market by acquiring assets in the United
States and Europe.
Also, CMOs are intensifying productivity in the competitive
market. The large CMOs are enlarging their regional prevalence and entering the
niche market through a merger. For example, SK Holdings, the holding company of
South Korea's SK Group, in 2019, launched a US-based contract manufacturing
organization (CMO), SK pharmteco, an association between SK biotek in Korea and
AMPAC Fine Chemicals (AFC) in the United States, which has assisted the market.
In accordance with the Association of Accessible Medicines, the US healthcare
system alone retained USD 313 billion in 2019. Medicare and Medicaid in the
same year saved USD 96 billion and USD 48.5 billion, respectively. Governments
across nations are encouraging the usage of these generic drugs owing to their
cost benefits. However, strict government norms associated with the production
of API and drugs is hampering the market growth.
Service
Segment Drivers
Based on the service, pharmaceutical manufacturing services
are expected to expand at a faster CAGR during the forecast period. This is
because of the excessive demand and consumption of generic drugs, which has
resulted in market growth. Additionally, the advantages like quality assurance,
economical, and advanced skill have bolstered the pharmaceutical contract
development and manufacturing market size.
Regional
Drivers
Based on the regional coverage, Asia-Pacific is projected to
expand at a higher CAGR in the market over the forecast period. This is
primarily attributed to the strategic measures by the countries like China,
India, and Japan. For instance, "Ministry of Health and Family Welfare
India" published US$ 9.30 billion under the 2020-2021 budget, which has
paved the way for market growth.
Pharmaceutical
Contract Development and Manufacturing Market’s leading Manufacturers:
·
Baxter BioPharma Solutions
·
Covance, Inc. (LabCorp)
·
Charles River Laboratories International, Inc.
·
Jubilant Life Sciences Limited
·
Lonza
·
QuintilesIMS
·
Albany Molecular Research, Inc.
·
Pfizer, Inc. (Pfizer CenterOne)
·
Grifols S.A
·
Boehringer Ingelheim GmbH
Pharmaceutical Contract Development and Manufacturing
Market Segmentation:
Segmentation by Service
·
Pharmaceutical Manufacturing Devices
·
Drug Development Services
·
Biologics Manufacturing Devices
Segmentation by End-User
·
Big Pharmaceutical Companies
·
Small & Medium Sized Pharmaceutical
Companies
·
Generic Pharmaceutical Companies
·
Others
Segmentation by Region:
·
North America
o
United States of America
o
Canada
·
Asia Pacific
o
China
o
Japan
o
India
o
Rest of APAC
·
Europe
o
United Kingdom
o
Germany
o
France
o
Spain
o
Rest of Europe
·
RoW
o
Brazil
o
South Africa
o
Saudi Arabia
o
UAE
o
Rest of the world (remaining countries of the
LAMEA region)
About GMI Research
GMI Research is a market research and consulting company
that offers business insights and market research reports for large and small
& medium enterprises. Our detailed reports help the clients to make
strategic business policies and achieve sustainable growth in the particular
market domain. The company's large team of seasoned analysts and industry
experts with experience from different regions such as Asia-Pacific, Europe,
North America, among others, provides a one-stop solution for the client. Our market
research report has in-depth analysis, which includes refined forecasts, a
bird's eye view of the competitive landscape, key factors influencing the
market growth, and various other market insights to aid companies in making
strategic decisions. Featured in the 'Top 20 Most Promising Market Research Consultants' list
of Silicon India Magazine in 2018, we at GMI Research are always looking
forward to helping our clients to stay ahead of the curve.
Media Contact
Company Name: GMI RESEARCH
Contact Person: Sarah Nash
Email: enquiry@gmiresearch.com
Phone: Europe – +353 1 442 8820; US – +1 860 881 2270
Address: Dublin, Ireland
Website: www.gmiresearch.com
Comments